North America to Hold the Lion’s Share in the Plasma Therapy Market

Tue, 02 June 2020 5:25

The plasma therapy market is primarily driven by its integral use in the healthcare industry for treating orthopedic injuries, cosmetic surgeries, and immunodeficiency disorders. Orthopedic injuries such as tendon injuries, rotator cuff, tennis elbow, and hamstring are quickly and effectively healed using plasma therapy.

Several medical conditions, such as erectile dysfunction and facelift surgeries, are treated using platelet-rich plasma therapy. Platelet-rich plasma is derived from blood plasma, consisting enriched platelets, which assists in quick healing of bone and other soft tissues. However, high cost of medical devices used in plasma therapy hampers market growth. Governments across the globe are actively working to develop plasma-derived medicines and organizing blood donation to ensure an adequate supply of blood plasma, further driving the market growth.  For instance, the government of India announced the national policy to access plasma-derived medicinal products for clinical and therapeutic use. 

Got questions about your regional growth of

Plasma Therapy Market?

Just drop us a line or call on +1 646 480 7505

Key Highlights

  • The plasma therapy market was valued at USD 205.15 million in 2019 and is expected to grow with a CAGR of 14.8% on account of increasing demand for plasma therapy and significant untapped therapeutic opportunities in the field of plasma therapy
  • The pure platelet rich plasma segment holds the largest market share owing to the effective results of pure PRP therapy and widespread applications in cosmetics, general, cardiovascular surgeries, and wound healing surgeries
  • The autologous segment is expected to account for the largest market share during the forecast period owing to its cost-effectiveness and low threat of disease transmission
  • North America leads the plasma therapy market as the region possesses well-established healthcare infrastructure, favorable regulatory framework, and government support

Key Players

  • BioLife Plasma Services
  • Grifols International S.A.
  • Biotest, CSL Ltd.
  • Cambryn Biologics LLC
  • Bio Products Laboratory Ltd.
  • China Biologic Products, Inc.
  • Kedrion S.p.A.
  • Octapharma
  • LFB biopharmaceutical

Recent Development

  • In January 2019, Takeda Pharma acquired Shire PLC. to increase R&D investment in order to develop plasma-derived therapies in four therapeutic areas, namely oncology, gastroenterology (GI), neuroscience, and rare diseases.

Plasma Therapy Market Segmentation

By Type

  • Pure platelet-rich plasma (PRP)
  • Leukocyte-rich PRP
  • Pure platelet-rich fibrin (PRF)
  • Leukocyte-rich fibrin (L-PRF)
  • Plasma proteins

By Source

  • Autologous
  • Allogenic

By Application

  • Orthopedic
  • Chronic infectious diseases
  • Dermatology
  • Dental
  • Cardiac muscle Injury
  • Nerve injury

By End-User

  • Hospitals and clinics
  • Research institutions

By Region

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • The Middle East and Africa

" Crucial Insights The Report Provides:"

* Known and Unknown Adjacencies Influencing the Growth of Market

* Explorable Revenue Sources

* Customer Behaviour Analysis

* Target Partners

* Customized Geographical Data Based on Customers as well as Competitors

* Analysis of Market Size and CAGR between the Forecast Periods

View Full Report Buy This Report Now